| Date Filed | Type | Description |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/29/2020 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 7,500 shares
@ $0 |
|
| 06/05/2020 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 15,000 options to buy
@ $1.01, valued at
$15.2k
|
|
| 07/18/2019 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 1,500 options to buy
@ $2.34, valued at
$3.5k
|
|
| 06/01/2018 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 25,000 options to buy
@ $4.24, valued at
$106k
|
|
| 03/02/2018 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp|
Txns:
| Granted 30,000 options to buy
@ $0 |
|
| 01/08/2018 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 50,000 options to buy
@ $2.11, valued at
$105.5k
|
|
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/04/2016 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on Zosano Pharma Corp |
| 10/03/2016 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 16,997 shares
@ $0.3383, valued at
$5.8k
|
|
| 07/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2013 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Sold 2,864 shares
@ $2.52, valued at
$7.2k
|
|
| 04/22/2013 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Sold 2,864 shares
@ $2.627, valued at
$7.5k
|
|
| 03/21/2013 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Sold 2,864 shares
@ $2.5, valued at
$7.2k
|
|
| 01/08/2013 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 16,000 options to buy
@ $2.1, valued at
$33.6k
|
|
| 10/04/2012 |
3
| XANTHOPOULOS KLEANTHIS G (President & CEO) has filed a Form 3 on Regulus Therapeutics Inc. |
| 10/01/2012 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Sold 3,125 shares
@ $3.2506, valued at
$10.2k
|
|
| 08/17/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2012 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on APRICUS BIOSCIENCES, INC.|
Txns:
| Granted 16,000 options to buy
@ $0 |
|
| 11/21/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/21/2011 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/27/2011 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on ANADYS PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $1.17, valued at
$17.6k
|
|
| 05/28/2010 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on ANADYS PHARMACEUTICALS INC|
Txns:
| Granted 15,000 options to buy
@ $2.3, valued at
$34.5k
|
|
| 05/29/2009 |
4
| XANTHOPOULOS KLEANTHIS G (Director) has filed a Form 4 on ANADYS PHARMACEUTICALS INC |